Transplant diagnostics refers to the diagnostics tests conducted on the organs meant to be transplanted. These tests are either conducted pre-transplantation or post-transplantation. Some of the common techniques used in transplant diagnostics are sequence-based molecular assays, PCR-based molecular assays, and non-molecular assays in certain cases. Transplant diagnostics is an essential factor in organ transplantation as it avoids any further complications that could occur after a transplant procedure.
North America is the largest market for transplant diagnostics with the US holding the largest market share followed by Canada. The market for transplant diagnostics in the US is expected to grow owing to the availability of advanced healthcare infrastructure, increasing number of transplant procedures as well as availability of skilled professionals. There has been a substantial increase in the number of transplant procedures conducted across the US. As per data published by US Department of Health & Human Services, there were around 36,527 organ transplants performed in the US in 2018. The country held an annual record for the sixth consecutive year, as per the Organ Procurement and Transplantation Network (OPTN). The rise in the number of organ transplant procedures along with the awareness regarding the importance of organ donation is expected to fuel growth of the market in the US during the forecast period.
The global transplant diagnostics market, based on product & services, is segmented into instruments, reagents & consumables and software & services. The reagents & consumables segment was the largest among the product & services subsegments in the transplant diagnostics market in 2018. However, the software & services segment is expected to witness growth in its demand at the fastest CAGR of 9.6% during 2019–2027. The global transplant diagnostics market, based on type, is segmented into solid organ transplantation, soft tissue transplantation, and stem cell transplantation. The solid organ transplantation segment held the largest share of the transplant diagnostics market in 2018 and is anticipated to continue to hold the largest market during the forecast period. The global transplant diagnostics market, based on technology, is segmented into molecular assays and non-molecular assays. In 2018, the molecular assays systems segment held a larger share of the market and is expected to witness growth in its demand at a faster CAGR of 9.5% during 2019–2027. The global transplant diagnostics market, based on application, is segmented into diagnostic applications and research applications. In 2018, the diagnostic applications segment held a larger share of the market and is expected to grow at a faster rate during 2019–2027.
Transplant Diagnostics Market: Competitive Landscape and Key Developments
Bio-Rad Laboratories; Biomerieux SA; Illumina SA; Thermo Fisher Scientific, Inc; Qiagen N.V; F. Hoffmann-La Roche LTD.; Hologic Inc.; Luminex Corporation; Omixon Inc.; and Abbott are among the leading companies in the transplant diagnostics market. The transplant diagnostics market share is anticipated to flourish with the development of new innovative products by market players.
- In April 2018, Qiagen launched QIAstat-Dxâ in Europe. The product launched has played an important role in oncology or transplantation surgeries, which improved treatment decisions.
- In April 2017, One Lambda announced the availability of the FDA approved and CE marked LAB Screen Multi screening kit for detecting HNA-3 and HLA. Additional benefits of the product include processing up to 96 samples in under 4 hours.
The organ transplantation surgeries are rising across the world. For instance, in Spain, approximately 5,260 transplant surgeries were performed, among which nearly 3,200 were kidney transplants and around 1,200 were liver transplant surgeries. The number of heart transplant surgeries were approximately 300 and lung were nearly 360. The public–private partnership in assistance with the transplant coordinators has enormously contributed to the improvement of organ transplantation. The developing and developed countries have shown significant number of organ transplantation surgeries. For instance, developing countries such as India and Singapore are emerging as medical tourism destinations in Asia Pacific. The countries are growing in terms of offering better and advanced medical treatments.
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876